BRGX Revenue first quarter 2027 Y/Y Growth Comment
Bioregenx, Inc. reported decline in Revenue in the first quarter 2027 by -18.04% to $ 0.43 millions, from the same quarter in 2026. The contraction in the first quarter 2027 Bioregenx, Inc.'s Revenue compares unfavorably to the Company's average Revenue doubling of 2618.47%.
According to the results reported in the first quarter 2027, Bioregenx, Inc. achieved the best Revenue growth in Internet Services & Social Media industry. While Bioregenx, Inc.' s Revenue fall of -18.04% ranks overall at the positon no. 0 in the first quarter 2027.
Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027
Bioregenx,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
11985.39 %
747.4 %
-24.06 %
(Mar 31 2023)
BRGX's I. Quarter Q/Q Revenue Comment
BIOREGENX, INC. achieved in the I. Quarter 2027 below company average Revenue increase of 9.28% quarter on quarter, to $ 0.43 millions.
Within Internet Services & Social Media industry BIOREGENX, INC. achieved highest sequential Revenue growth. While Bioregenx,'s Revenue growth quarter on quarter, overall rank is 0.
BIOREGENX, INC. achieved in the I. Quarter 2027 below company average Revenue increase of 9.28% quarter on quarter, to $ 0.43 millions.
Within Internet Services & Social Media industry BIOREGENX, INC. achieved highest sequential Revenue growth. While Bioregenx,'s Revenue growth quarter on quarter, overall rank is 0.
Bioregenx,'s 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
12 Months Ending (Mar 31 2025)
Cumulative Revenue 12 Months Ending
$ 1.77
$ 1.85
$ 1.93
$ 2.02
$ 2.31
Y / Y Revenue Growth (TTM)
-23.42 %
-20.75 %
-24.56 %
-26.79 %
-20.09 %
Year on Year Revenue Growth Overall
Ranking
# 3486
# 4039
# 3545
# 3587
# 3525
Seqeuential Revenue Change (TTM)
-4.79 %
-3.89 %
-4.37 %
-12.49 %
-1.47 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 3486
# 4039
# 3545
# 3587
# 3525
Cumulative Revenue growth Comment
Bioregenx,'s cumulative 12 months Revenue continue to fall, but on the faster rate at -23.42% year on year, at Mar 31 2026 compare to the -20.75% decrease at Dec 31 2025. If the Bioregenx,'s fiscal year would end at Mar 31 2026, annual Revenue would be $2 millions.
BIOREGENX, INC. achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 3486, from total ranking in previous quarter at 4039.
Bioregenx,'s cumulative 12 months Revenue continue to fall, but on the faster rate at -23.42% year on year, at Mar 31 2026 compare to the -20.75% decrease at Dec 31 2025. If the Bioregenx,'s fiscal year would end at Mar 31 2026, annual Revenue would be $2 millions.
BIOREGENX, INC. achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 3486, from total ranking in previous quarter at 4039.
About Bioregenx, Revenue Growth Rates (BRGX), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
